PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,323 | -58.6% | 695 | -50.0% | 0.00% | 0.0% |
Q2 2023 | $51,479 | +117.9% | 1,390 | +100.0% | 0.00% | 0.0% |
Q1 2023 | $23,630 | +90784.6% | 695 | -5.6% | 0.00% | 0.0% |
Q4 2022 | $26 | -99.9% | 736 | -20.7% | 0.00% | 0.0% |
Q3 2022 | $36,000 | 0.0% | 928 | +1.2% | 0.00% | 0.0% |
Q2 2022 | $36,000 | -40.0% | 917 | -43.1% | 0.00% | 0.0% |
Q1 2022 | $60,000 | +42.9% | 1,612 | +131.9% | 0.00% | 0.0% |
Q4 2021 | $42,000 | +7.7% | 695 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $39,000 | +1850.0% | 695 | +2680.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 25 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | -77.8% | 25 | -83.4% | 0.00% | – |
Q4 2020 | $9,000 | -88.9% | 151 | -88.9% | 0.00% | -100.0% |
Q3 2020 | $81,000 | – | 1,358 | – | 0.01% | – |
Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2018 | $9,000 | +200.0% | 200 | +100.0% | 0.00% | – |
Q4 2016 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q3 2016 | $3,000 | -25.0% | 100 | -9.9% | 0.00% | – |
Q2 2016 | $4,000 | -50.0% | 111 | +11.0% | 0.00% | -100.0% |
Q4 2015 | $8,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |